References
- Adamzik, M., Frey, U., Sixt, S., Knemeyer, L., Beiderlinden, M.,
Peters, J., & Siffert, W. (2007). ACE I/D but not AGT (-6) A/G
polymorphism is a risk factor for mortality in ARDS. European
Respiratory Journal, 29(3), 482-488.
- Adedeji, A. O., & Sarafianos, S. G. (2014). Antiviral drugs specific
for coronaviruses in preclinical development. Current opinion in
virology, 8, 45-53.
- Adedeji, A. O., Severson, W., Jonsson, C., Singh, K., Weiss, S. R., &
Sarafianos, S. G. (2013). Novel inhibitors of severe acute respiratory
syndrome coronavirus entry that act by three distinct mechanisms.
Journal of virology, 87(14), 8017-8028.
- Alexander, S. P., Battey, J., Benson, H. E., Benya, R. V., Bonner, T.
I., Davenport, A. P., … & Karnik, S. (2019). Class A Orphans
(version 2019.5) in the IUPHAR/BPS Guide to Pharmacology Database.
IUPHAR/BPS Guide to Pharmacology CITE, 2019(5).
- Andreeva, A. V., Kutuzov, M. A., & Voyno-Yasenetskaya, T. A. (2007).
Regulation of surfactant secretion in alveolar type II cells. American
Journal of Physiology-Lung Cellular and Molecular Physiology, 293(2),
L259-L271.
- Armstrong, J. F., Faccenda, E., Harding, S. D., Pawson, A. J.,
Southan, C., Sharman, J. L., … & Spedding, M. (2020). The
IUPHAR/BPS Guide to PHARMACOLOGY in 2020: extending immunopharmacology
content and introducing the IUPHAR/MMV Guide to MALARIA PHARMACOLOGY.
Nucleic acids research, 48(D1), D1006-D1021.
- Arumugam, S., Sreedhar, R., Thandavarayan, R. A., Karuppagounder, V.,
Krishnamurthy, P., Suzuki, K., … & Watanabe, K. (2016). Angiotensin
receptor blockers: Focus on cardiac and renal injury. Trends in
cardiovascular medicine, 26(3), 221-228.
- Attaway, A. H., Myers, C., Velani, S., & Schilz, R. (2017). Inhaled
Prostacyclin as Salvage Therapy for ARDS: Can We Find the Right
Patient?
- Aumiller, V., Balsara, N., Wilhelm, J., Günther, A., & Königshoff, M.
(2013). WNT/β-catenin signaling induces IL-1β expression by alveolar
epithelial cells in pulmonary fibrosis. American journal of
respiratory cell and molecular biology, 49(1), 96-104.
- Baker, K. M., Booz, G. W., & Dostal, D. E. (1992). Cardiac actions of
angiotensin II: role of an intracardiac renin-angiotensin system.
Annual review of physiology, 54(1), 227-241.
- Bao, L., Deng, W., Gao, H., Xiao, C., Liu, J., Xue, J., … & Qi, F.
(2020). Reinfection could not occur in SARS-CoV-2 infected rhesus
macaques. bioRxiv. doi: https://doi.org/10.1101/2020.03.13.990226
- Bar-On, Y. M., Flamholz, A., Phillips, R., & Milo, R. (2020).
SARS-CoV-2 (COVID-19) by the numbers. eLife, 9, e57309.
- Barroso, L. C., Magalhaes, G. S., Galvão, I., Reis, A. C., Souza, D.
G., Sousa, L. P., … & Teixeira, M. M. (2017). Angiotensin-(1-7)
promotes resolution of neutrophilic inflammation in a model of
antigen-induced arthritis in mice. Frontiers in immunology, 8, 1596.
- Bechara, R. I., Brown, L. A. S., Eaton, D. C., Roman, J., & Guidot,
D. M. (2003). Chronic ethanol ingestion increases expression of the
angiotensin II type 2 (AT2) receptor and enhances tumor necrosis
factor‐α‐and angiotensin II‐induced cytotoxicity via AT2 signaling in
rat alveolar epithelial cells. Alcoholism: Clinical and Experimental
Research, 27(6), 1006-1014.
- Becker, L. K., Totou, N., Moura, S., Kangussu, L., Millán, R. D. S.,
Campagnole-Santos, M. J., … & Santos, R. A. S. (2018). Eccentric
overload muscle damage is attenuated by a novel angiotensin-(1-7)
treatment. International journal of sports medicine, 39(10), 743-748.
- Bhattacharya, J., & Westphalen,
K. (2016, July). Macrophage-epithelial interactions in pulmonary
alveoli. In Seminars in immunopathology (Vol. 38, No. 4, pp. 461-469).
Springer Berlin Heidelberg.
- Bodor, C., Nagy, J. P., Végh, B., Németh, A., Jenei, A.,
MirzaHosseini, S., … & Rosivall, L. (2012). Angiotensin II
increases the permeability and PV-1 expression of endothelial cells.
American Journal of Physiology-Cell Physiology, 302(1), C267-C276.
- Boskabadi, J., Askari, V. R., Hosseini, M., & Boskabady, M. H.
(2019). Immunomodulatory properties of captopril, an ACE inhibitor, on
LPS-induced lung inflammation and fibrosis as well as oxidative
stress. Inflammopharmacology, 27(3), 639-647.
- Bozkurt, B., Kovacs, R., & Harrington, B. (2020). HFSA/ACC/AHA
Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19.
American Heart Association Professional Heart Daily.
- Buckley, S. T., Medina, C., & Ehrhardt, C. (2010). Differential
susceptibility to epithelial-mesenchymal transition (EMT) of alveolar,
bronchial and intestinal epithelial cells in vitro and the effect of
angiotensin II receptor inhibition. Cell and tissue research, 342(1),
39-51.
- Caldeira, D., Alarcão, J., Vaz-Carneiro, A., & Costa, J. (2012). Risk
of pneumonia associated with use of angiotensin converting enzyme
inhibitors and angiotensin receptor blockers: systematic review and
meta-analysis. Bmj, 345, e4260.
- Castelo-Branco, C., & Soveral, I. (2014). The immune system and
aging: a review. Gynecological Endocrinology, 30(1), 16-22.
- Channappanavar, R., & Perlman,
S. (2017, July). Pathogenic human coronavirus infections: causes and
consequences of cytokine storm and immunopathology. In Seminars in
immunopathology (Vol. 39, No. 5, pp. 529-539). Springer Berlin
Heidelberg.
- Channappanavar, R., Zhao, J., & Perlman, S. (2014). T cell-mediated
immune response to respiratory coronaviruses. Immunologic research,
59(1-3), 118-128.
- Chen, C., Zhang, Z., Li, Z., Zhang, F., Peng, M., Chen, Y., & Wang,
Y. (2014). Losartan attenuates microvascular permeability in
mechanical ventilator-induced lung injury in diabetic mice. Molecular
biology reports, 41(2), 809-814.
- Chen, C., Zhou, Y., & Wang, D. W. (2020). SARS-CoV-2: a potential
novel etiology of fulminant myocarditis. Herz, 1-3.
- Chuquimia, O. D., Petursdottir, D. H., Rahman, M. J., Hartl, K.,
Singh, M., & Fernández, C. (2012). The role of alveolar epithelial
cells in initiating and shaping pulmonary immune responses:
communication between innate and adaptive immune systems. PloS one,
7(2).
- Cohen, E. P., Bedi, M., Irving, A. A., Jacobs, E., Tomic, R., Klein,
J., … & Moulder, J. E. (2012). Mitigation of late renal and
pulmonary injury after hematopoietic stem cell transplantation.
International Journal of Radiation Oncology* Biology* Physics, 83(1),
292-296.
- da Silveira, K. D., Coelho, F. M., Vieira, A. T., Sachs, D., Barroso,
L. C., Costa, V. V., … & dos Santos, R. A. S. (2010).
Anti-inflammatory effects of the activation of the angiotensin-(1–7)
receptor, MAS, in experimental models of arthritis. The Journal of
Immunology, 185(9), 5569-5576.
- De Mello, W. C., & Danser, A. J. (2000). Angiotensin II and the
heart: on the intracrine renin-angiotensin system. Hypertension,
35(6), 1183-1188.
- Deng, J., Wang, D. X., Deng, W., Li, C. Y., & Tong, J. (2012a). The
effect of endogenous angiotensin II on alveolar fluid clearance in
rats with acute lung injury. Canadian respiratory journal, 19(5),
311-318.
- Deng, J., Wang, D. X., Deng, W., Li, C. Y., Tong, J., & Ma, H.
(2012b). Regulation of alveolar fluid clearance and ENaC expression in
lung by exogenous angiotensin II. Respiratory physiology &
neurobiology, 181(1), 53-61.
- Dhama, K.; Patel, S.K.; Pathak, M.; Yatoo, M.I.; Tiwari, R.; …
& Rodriguez-Morales, A.J. An Update on SARS-COV-2/COVID-19 with
Particular Reference on Its Clinical Pathology, Pathogenesis,
Immunopathology and Mitigation Strategies – A Review. Preprints 2020,
2020030348 (doi: 10.20944/preprints202003.0348.v1)
- Dijkman, R., Jebbink, M. F., Deijs, M., Milewska, A., Pyrc, K.,
Buelow, E., … & van der Hoek, L. (2012). Replication-dependent
downregulation of cellular angiotensin-converting enzyme 2 protein
expression by human coronavirus NL63. Journal of general virology,
93(9), 1924-1929.
- Donath, M. Y., Meier, D. T., & Böni-Schnetzler, M. (2019).
Inflammation in the pathophysiology and therapy of cardiometabolic
disease. Endocrine reviews, 40(4), 1080-1091.
- Dostal, D. E., & Baker, K. M. (1999). The cardiac renin-angiotensin
system: conceptual, or a regulator of cardiac function?. Circulation
research, 85(7), 643-650.
- Du, Y., Tu, L., Zhu, P., Mu, M., Wang, R., Yang, P., … & Li, T.
(2020). Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan: A
Retrospective Observational Study. American Journal of Respiratory and
Critical Care Medicine, (ja).
- Eisele, N. A., & Anderson, D.
M. (2011). Host defense and the airway epithelium: frontline responses
that protect against bacterial invasion and pneumonia. Journal of
pathogens, 2011.
- Fang, L., Karakiulakis, G., & Roth, M. (2020). Are patients with
hypertension and diabetes mellitus at increased risk for COVID-19
infection? The Lancet Respiratory Medicine. 8(4), PE-21
- Ferrucci, L., & Fabbri, E. (2018). Inflammageing: chronic
inflammation in ageing, cardiovascular disease, and frailty. Nature
Reviews Cardiology, 15(9), 505-522.
- Flores‐Muñoz, M., Smith, N. J., Haggerty, C., Milligan, G., &
Nicklin, S. A. (2011). Angiotensin1‐9 antagonises pro‐hypertrophic
signalling in cardiomyocytes via the angiotensin type 2 receptor. The
journal of Physiology, 589(4), 939-951.
- Florez‐Sampedro, L., Song, S.,
& Melgert, B. N. (2018). The diversity of myeloid immune cells
shaping wound repair and fibrosis in the lung. Regeneration, 5(1),
3-25.
- Forrester, S. J., Booz, G. W., Sigmund, C. D., Coffman, T. M., Kawai,
T., Rizzo, V., … & Eguchi, S. (2018). Angiotensin II signal
transduction: an update on mechanisms of physiology and
pathophysiology. Physiological reviews, 98(3), 1627-1738.
- Frieler, R. A., & Mortensen, R. M. (2015). Immune cell and other
noncardiomyocyte regulation of cardiac hypertrophy and remodeling.
Circulation, 131(11), 1019-1030.
- Fulop, T., Larbi, A., Dupuis, G., Le Page, A., Frost, E. H., Cohen, A.
A., … & Franceschi, C. (2018). Immunosenescence and inflamm-aging
as two sides of the same coin: friends or foes?. Frontiers in
immunology, 8, 1960.
- Gard, P. R. (2010). Implications of the angiotensin converting enzyme
gene insertion/deletion polymorphism in health and disease: a snapshot
review. International journal of molecular epidemiology and genetics,
1(2), 145.
- Gautret, P., Lagier, J. C., Parola, P., Meddeb, L., Mailhe, M.,
Doudier, B., … & Honoré, S. (2020). Hydroxychloroquine and
azithromycin as a treatment of COVID-19: results of an open-label
non-randomized clinical trial. International Journal of Antimicrobial
Agents, 105949.
- Glowacka, I., Bertram, S., Herzog, P., Pfefferle, S., Steffen, I.,
Muench, M. O., … & Eichler, J. (2010). Differential downregulation
of ACE2 by the spike proteins of severe acute respiratory syndrome
coronavirus and human coronavirus NL63. Journal of virology, 84(2),
1198-1205.
- Godugu, C., Patel, A. R., Doddapaneni, R., Marepally, S., Jackson, T.,
& Singh, M. (2013). Inhalation delivery of Telmisartan enhances
intratumoral distribution of nanoparticles in lung cancer models.
Journal of controlled release, 172(1), 86-95.
- Gralinski, L. E., & Baric, R. S. (2015). Molecular pathology of
emerging coronavirus infections. The Journal of pathology, 235(2),
185-195.
- Gretebeck, L. M., & Subbarao, K. (2015). Animal models for SARS and
MERS coronaviruses. Current opinion in virology, 13, 123-129.
- Grommes, J., & Soehnlein, O. (2011). Contribution of neutrophils to
acute lung injury. Molecular medicine, 17(3), 293.
- Gu, J., Han, B., & Wang, J. (2020). COVID-19: Gastrointestinal
manifestations and potential fecal-oral transmission.
Gastroenterology.
- Guo, T., Fan, Y., Chen, M., Wu, X., Zhang, L., He, T., … & Lu, Z.
(2020). Cardiovascular implications of fatal outcomes of patients with
coronavirus disease 2019 (COVID-19). JAMA cardiology.
- Haga, S., Yamamoto, N., Nakai-Murakami, C., Osawa, Y., Tokunaga, K.,
Sata, T., … & Ishizaka, Y. (2008). Modulation of TNF-α-converting
enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-α
production and facilitates viral entry. Proceedings of the National
Academy of Sciences, 105(22), 7809-7814.
- Hammer, A., Yang, G., Friedrich, J., Kovacs, A., Lee, D. H., Grave,
K., … & Gold, R. (2016). Role of the receptor Mas in
macrophage-mediated inflammation in vivo. Proceedings of the National
Academy of Sciences, 113(49), 14109-14114.
- Hamming, I., Timens, W., Bulthuis, M. L. C., Lely, A. T., Navis, G.
J., & van Goor, H. (2004). Tissue distribution of ACE2 protein, the
functional receptor for SARS coronavirus. A first step in
understanding SARS pathogenesis. The Journal of Pathology: A Journal
of the Pathological Society of Great Britain and Ireland, 203(2),
631-637.
- Han, D. P., Penn-Nicholson, A., & Cho, M. W. (2006). Identification
of critical determinants on ACE2 for SARS-CoV entry and development of
a potent entry inhibitor. Virology, 350(1), 15-25.
- Han, S. X., He, G. M., Wang, T., Chen, L., Ning, Y. Y., Luo, F., …
& Xu, D. (2010). Losartan attenuates chronic cigarette smoke
exposure-induced pulmonary arterial hypertension in rats: possible
involvement of angiotensin-converting enzyme-2. Toxicology and applied
pharmacology, 245(1), 100-107.
- Harder, E. M., Park, H. S., Nath, S. K., Mancini, B. R., & Decker, R.
H. (2015). Angiotensin-converting enzyme inhibitors decrease the risk
of radiation pneumonitis after stereotactic body radiation therapy.
Practical radiation oncology, 5(6), e643-e649.
- He, F., Deng, Y., & Li, W. (2020). Coronavirus Disease 2019
(COVID‐19): What we know?. Journal of Medical Virology.
- He, H., Liu, L., Chen, Q., Liu, A., Cai, S., Yang, Y., … & Qiu, H.
(2015). Mesenchymal stem cells overexpressing angiotensin-converting
enzyme 2 rescue lipopolysaccharide-induced lung injury. Cell
transplantation, 24(9), 1699-1715.
- He, X., Han, B., Mura, M., Xia, S., Wang, S., Ma, T., … & Liu, Z.
(2007). Angiotensin-converting enzyme inhibitor captopril prevents
oleic acid-induced severe acute lung injury in rats. Shock, 28(1),
106-111.
- Herold, S., Ludwig, S., Pleschka, S., & Wolff, T. (2012). Apoptosis
signaling in influenza virus propagation, innate host defense, and
lung injury. Journal of leukocyte biology, 92(1), 75-82.
- Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., … & Cheng,
Z. (2020). Clinical features of patients infected with 2019 novel
coronavirus in Wuhan, China. The Lancet, 395(10223), 497-506.
- Hui, D. S., Joynt, G. M., Wong, K. T., Gomersall, C. D., Li, T. S.,
Antonio, G., … & Rainer, T. H. (2005). Impact of severe acute
respiratory syndrome (SARS) on pulmonary function, functional capacity
and quality of life in a cohort of survivors. Thorax, 60(5), 401-409.
- Hung, I. F. N., Cheng, V. C. C., Wu, A. K. L., Tang, B. S. F., Chan,
K. H., Chu, C. M., … & Chan, K. S. (2004). Viral loads in clinical
specimens and SARS manifestations. Emerging infectious diseases,
10(9), 1550.
- Imai, Y., Kuba, K., Rao, S., Huan, Y., Guo, F., Guan, B., … &
Crackower, M. A. (2005). Angiotensin-converting enzyme 2 protects from
severe acute lung failure. Nature, 436(7047), 112-116.
- Inoue, Y., Tanaka, N., Tanaka, Y., Inoue, S., Morita, K., Zhuang, M.,
… & Sugamura, K. (2007). Clathrin-dependent entry of severe acute
respiratory syndrome coronavirus into target cells expressing ACE2
with the cytoplasmic tail deleted. Journal of virology, 81(16),
8722-8729.
- Ismael-Badarneh, R., Guetta, J., Klorin, G., Berger, G., Abu-saleh,
N., Abassi, Z., & Azzam, Z. S. (2015). The role of angiotensin II and
cyclic AMP in alveolar active sodium transport. PloS one, 10(7).
- Itoyama, S., Keicho, N., Quy, T., Phi, N. C., Long, H. T., Van Ban,
V., … & Yanai, H. (2004). ACE1 polymorphism and progression of
SARS. Biochemical and biophysical research communications, 323(3),
1124-1129.
- Jerng, J. S., Hsu, Y. C., Wu, H. D., Pan, H. Z., Wang, H. C., Shun, C.
T., … & Yang, P. C. (2007). Role of the renin-angiotensin system in
ventilator-induced lung injury: an in vivo study in a rat model.
Thorax, 62(6), 527-535.
- Jiang, J. S., Wang, L. F., Chou, H. C., & Chen, C. M. (2007).
Angiotensin-converting enzyme inhibitor captopril attenuates
ventilator-induced lung injury in rats. Journal of applied physiology,
102(6), 2098-2103.
- Jones, E. S., Vinh, A., McCarthy, C. A., Gaspari, T. A., & Widdop, R.
E. (2008). AT2 receptors: functional relevance in cardiovascular
disease. Pharmacology & therapeutics, 120(3), 292-316.
- Kam, K. Q., Yung, C. F., Cui, L., Tzer Pin Lin, R., Mak, T. M.,
Maiwald, M., … & Thoon, K. C. (2020). A Well Infant with
Coronavirus Disease 2019 with High Viral Load. Clinical Infectious
Diseases.
- Karnik, S. S., Singh, K. D., Tirupula, K., & Unal, H. (2017).
Significance of angiotensin 1–7 coupling with MAS1 receptor and other
GPCRs to the renin‐angiotensin system: IUPHAR Review 22. British
journal of pharmacology, 174(9), 737-753.
- Kaschina, E., & Unger, T. (2003). Angiotensin AT1/AT2 receptors:
regulation, signalling and function. Blood pressure, 12(2), 70-88.
- Ketai, L., Paul, N. S., & Ka-tak, T. W. (2006). Radiology of severe
acute respiratory syndrome (SARS): the emerging pathologic-radiologic
correlates of an emerging disease. Journal of thoracic imaging, 21(4),
276-283.
- Khan, A., Benthin, C., Zeno, B., Albertson, T. E., Boyd, J., Christie,
J. D., … & Hardes, K. (2017). A pilot clinical trial of recombinant
human angiotensin-converting enzyme 2 in acute respiratory distress
syndrome. Critical Care, 21(1), 234.
- Khan, A., Benthin, C., Zeno, B., Albertson, T. E., Boyd, J., Christie,
J. D., … & Hardes, K. (2017). A pilot clinical trial of recombinant
human angiotensin-converting enzyme 2 in acute respiratory distress
syndrome. Critical Care, 21(1), 234.
- Kharofa, J., Cohen, E. P., Tomic, R., Xiang, Q., & Gore, E. (2012).
Decreased risk of radiation pneumonitis with incidental concurrent use
of angiotensin-converting enzyme inhibitors and thoracic radiation
therapy. International Journal of Radiation Oncology* Biology*
Physics, 84(1), 238-243.
- Kim, M. D., Baumlin, N., Yoshida, M., Polineni, D., Salathe, S. F.,
David, J. K., … & Whitney, P. (2020). Losartan rescues
inflammation-related mucociliary dysfunction in relevant models of
cystic fibrosis. American journal of respiratory and critical care
medicine, 201(3), 313-324.
- Kode, A., Yang, S. R., & Rahman, I. (2006). Differential effects of
cigarette smoke on oxidative stress and proinflammatory cytokine
release in primary human airway epithelial cells and in a variety of
transformed alveolar epithelial cells. Respiratory research, 7(1),
132.
- Konigshoff, M., Wilhelm, A., Jahn, A., Sedding, D., Amarie, O. V.,
Eul, B., … & Rose, F. (2007). The angiotensin II receptor 2 is
expressed and mediates angiotensin II signaling in lung fibrosis.
American journal of respiratory cell and molecular biology, 37(6),
640-650.
- Kruse, R. L. (2020). Therapeutic strategies in an outbreak scenario to
treat the novel coronavirus originating in Wuhan, China.
F1000Research, 9.
- Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., … & Bao,
L. (2005). A crucial role of angiotensin converting enzyme 2 (ACE2) in
SARS coronavirus–induced lung injury. Nature medicine, 11(8),
875-879.
- Kuba, K., Imai, Y., Rao, S., Jiang, C., & Penninger, J. M. (2006).
Lessons from SARS: control of acute lung failure by the SARS receptor
ACE2. Journal of molecular medicine, 84(10), 814-820.
- Kurdi, M., & Booz, G. W. (2011). New take on the role of angiotensin
II in cardiac hypertrophy and fibrosis. Hypertension, 57(6),
1034-1038.
- Lambert, D. W., Yarski, M., Warner, F. J., Thornhill, P., Parkin, E.
T., Smith, A. I., … & Turner, A. J. (2005). Tumor necrosis factor-α
convertase (ADAM17) mediates regulated ectodomain shedding of the
severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor,
angiotensin-converting enzyme-2 (ACE2). Journal of Biological
Chemistry, 280(34), 30113-30119.
- Lee, J. H., Kim, J. H., Kim, J. S., Chang, J. W., Kim, S. B., Park, J.
S., & Lee, S. K. (2013). AMP-activated protein kinase inhibits
TGF-β-, angiotensin II-, aldosterone-, high glucose-, and
albumin-induced epithelial-mesenchymal transition. American Journal of
Physiology-Renal Physiology, 304(6), F686-F697.
- Lee, Y. H., Mungunsukh, O., Tutino, R. L., Marquez, A. P., & Day, R.
M. (2010). Angiotensin-II-induced apoptosis requires regulation of
nucleolin and Bcl-xL by SHP-2 in primary lung endothelial cells.
Journal of cell science, 123(10), 1634-1643.
- Lemarié, C. A., & Schiffrin, E. L. (2010). The angiotensin II type 2
receptor in cardiovascular disease. Journal of the
renin-angiotensin-aldosterone system, 11(1), 19-31.
- Li, C. K. F., Wu, H., Yan, H., Ma, S., Wang, L., Zhang, M., … &
Douek, D. C. (2008). T cell responses to whole SARS coronavirus in
humans. The Journal of Immunology, 181(8), 5490-5500.
- Li, G., Fan, Y., Lai, Y., Han, T., Li, Z., Zhou, P., … & Zhang, Q.
(2020). Coronavirus infections and immune responses. Journal of
medical virology, 92(4), 424-432.
- Li, X., Molina-Molina, M., Abdul-Hafez, A., Uhal, V., Xaubet, A., &
Uhal, B. D. (2008b). Angiotensin converting enzyme-2 is protective but
downregulated in human and experimental lung fibrosis. American
Journal of Physiology-Lung Cellular and Molecular Physiology, 295(1),
L178-L185.
- Li, X., Rayford, H., & Uhal, B. D. (2003). Essential roles for
angiotensin receptor AT1a in bleomycin-induced apoptosis and lung
fibrosis in mice. The American journal of pathology, 163(6),
2523-2530.
- Li, X., Zhuang, J., Rayford, H., Zhang, H., Shu, R., & Uhal, B. D.
(2007). Attenuation of bleomycin-induced pulmonary fibrosis by
intratracheal administration of antisense oligonucleotides against
angiotensinogen mRNA. Current pharmaceutical design, 13(12),
1257-1268.
- Li, Y., Zeng, Z., Li, Y., Huang, W., Zhou, M., Zhang, X., & Jiang, W.
(2015). Angiotensin-converting enzyme inhibition attenuates
lipopolysaccharide-induced lung injury by regulating the balance
between angiotensin-converting enzyme and angiotensin-converting
enzyme 2 and inhibiting mitogen-activated protein kinase activation.
Shock, 43(4), 395-404.
- Liu, J., Zhang, P. S., Yu, Q., Liu, L., Yang, Y., Guo, F. M., & Qiu,
H. B. (2012). Losartan inhibits conventional dendritic cell maturation
and Th1 and Th17 polarization responses: Νovel mechanisms of
preventive effects on lipopolysaccharide-induced acute lung injury.
International journal of molecular medicine, 29(2), 269-276.
- Liu, P., Wysocki, J., Souma, T., Ye, M., Ramirez, V., Zhou, B., … &
Jin, J. (2018). Novel ACE2-Fc chimeric fusion provides long-lasting
hypertension control and organ protection in mouse models of systemic
renin angiotensin system activation. Kidney international, 94(1),
114-125.
- Liu, Y., Huang, F., Xu, J., Yang, P., Qin, Y., Cao, M., … & Lv, J.
(2020). Anti-hypertensive Angiotensin II receptor blockers associated
to mitigation of disease severity in elderly COVID-19 patients.
medRxiv. doi: https://doi.org/10.1101/2020.03.20.20039586
- Liu, Y., Yang, Y., Zhang, C., Huang, F., Wang, F., Yuan, J., … &
Zhang, Z. (2020b). Clinical and biochemical indexes from 2019-nCoV
infected patients linked to viral loads and lung injury. Science China
Life Sciences, 63(3), 364-374.
- Lukkarinen, H. P., Laine, J., Aho, H., Zagariya, A., Vidyasagar, D.,
& Kääpä, P. O. (2005). Angiotensin II receptor inhibition prevents
pneumocyte apoptosis in surfactant‐depleted rat lungs. Pediatric
pulmonology, 39(4), 349-358.
- Luo, W., Yu, H., Gou, J., Li, X., Sun, Y., Li, J., & Liu, L. (2020).
Clinical pathology of critical patient with novel coronavirus
pneumonia (COVID-19). Pathology & Pathobiology, 2020020407.
- Ma, X., Xu, D., Ai, Y., Ming, G., & Zhao, S. (2010). Fas inhibition
attenuates lipopolysaccharide-induced apoptosis and cytokine release
of rat type II alveolar epithelial cells. Molecular biology reports,
37(7), 3051-3056.
- Magalhães, G. S., Rodrigues-Machado, M. G., Motta-Santos, D., Alenina,
N., Bader, M., Santos, R. A., … & Campagnole-Santos, M. J. (2016).
Chronic allergic pulmonary inflammation is aggravated in
angiotensin-(1–7) Mas receptor knockout mice. American Journal of
Physiology-Lung Cellular and Molecular Physiology, 311(6),
L1141-L1148.
- Mancini, G. J., Etminan, M., Zhang, B., Levesque, L. E., FitzGerald,
J. M., & Brophy, J. M. (2006). Reduction of morbidity and mortality
by statins, angiotensin-converting enzyme inhibitors, and angiotensin
receptor blockers in patients with chronic obstructive pulmonary
disease. Journal of the American College of Cardiology, 47(12),
2554-2560.
- Marshall, R. P., McANULTY, R. J., & Laurent, G. J. (2000).
Angiotensin II is mitogenic for human lung fibroblasts via activation
of the type 1 receptor. American journal of respiratory and critical
care medicine, 161(6), 1999-2004.
- Medhora, M., Gao, F., Jacobs, E. R., & Moulder, J. E. (2012).
Radiation damage to the lung: Mitigation by angiotensin‐converting
enzyme (ACE) inhibitors. Respirology, 17(1), 66-71.
- Meng, Y., Li, T., Zhou, G. S., Chen, Y., Yu, C. H., Pang, M. X., …
& Li, X. (2015). The angiotensin-converting enzyme 2/angiotensin
(1–7)/Mas axis protects against lung fibroblast migration and lung
fibrosis by inhibiting the NOX4-derived ROS-mediated RhoA/Rho kinase
pathway. Antioxidants & redox signaling, 22(3), 241-258.
- Meng, Y., Yu, C. H., Li, W., Li, T., Luo, W., Huang, S., … & Li, X.
(2014). Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis
protects against lung fibrosis by inhibiting the MAPK/NF-κB pathway.
American journal of respiratory cell and molecular biology, 50(4),
723-736.
- Mohammadi-Karakani, A., Ghazi-Khansari, M., & Sotoudeh, M. (2006).
Lisinopril ameliorates paraquat-induced lung fibrosis. Clinica chimica
acta, 367(1-2), 170-174.
- Molteni, A., Wolfe, L. F., Ward, W. F., Hsin Ts’ ao, C., Brizio
Molteni, L., Veno, P., … & Moulder, J. E. (2007). Effect of an
angiotensin II receptor blocker and two angiotensin converting enzyme
inhibitors on transforming growth factor-β (TGF-β) and α-Actomyosin (α
SMA), important mediators of radiation-induced pneumopathy and lung
fibrosis. Current pharmaceutical design, 13(13), 1307-1316.
- Monteil, V., Kwon, H., Prado, P., Hagelkrüys, A., Wimmer, R. A.,
Stahl, M., … & Romero, J. P. (2020). Inhibition of SARS-CoV-2
infections in engineered human tissues using clinical-grade soluble
human ACE2. Cell, DOI: 10.1016/j.cell.2020.04.004. Monteiro, R., &
Azevedo, I. (2010). Chronic inflammation in obesity and the metabolic
syndrome. Mediators of inflammation, 2010.
- Mortensen, E. M., Nakashima, B., Cornell, J., Copeland, L. A., Pugh,
M. J., Anzueto, A., … & Fine, M. J. (2012). Population-based study
of statins, angiotensin II receptor blockers, and
angiotensin-converting enzyme inhibitors on pneumonia-related
outcomes. Clinical infectious diseases, 55(11), 1466-1473.
- Mortensen, E. M., Restrepo, M. I., Anzueto, A., & Pugh, J. (2005).
The impact of prior outpatient ACE inhibitor use on 30-day mortality
for patients hospitalized with community-acquired pneumonia. BMC
pulmonary medicine, 5(1), 12.
- Mossel, E. C., Wang, J., Jeffers, S., Edeen, K. E., Wang, S.,
Cosgrove, G. P., … & Holmes, K. V. (2008). SARS-CoV replicates in
primary human alveolar type II cell cultures but not in type I-like
cells. Virology, 372(1), 127-135.
- Naicker, S., Yang, C. W., Hwang, S. J., Liu, B. C., Chen, J. H., &
Jha, V. (2020). The novel coronavirus 2019 epidemic and kidneys.
Kidney International.
- Noveanu, M., Breidthardt, T., Reichlin, T., Gayat, E., Potocki, M.,
Pargger, H., … & Mebazaa, A. (2010). Effect of oral beta-blocker on
short and long-term mortality in patients with acute respiratory
failure: results from the BASEL-II-ICU study. Critical care, 14(6),
R198.
- Otsuka, M., Takahashi, H., Shiratori, M., Chiba, H., & Abe, S.
(2004). Reduction of bleomycin induced lung fibrosis by candesartan
cilexetil, an angiotensin II type 1 receptor antagonist. Thorax,
59(1), 31-38.
- Oudit, G. Y., Kassiri, Z., Jiang, C., Liu, P. P., Poutanen, S. M.,
Penninger, J. M., & Butany, J. (2009). SARS‐coronavirus modulation of
myocardial ACE2 expression and inflammation in patients with SARS.
European journal of clinical investigation, 39(7), 618-625.
- Pan, F., Ye, T., Sun, P., Gui, S., Liang, B., Li, L., … & Zheng, C.
(2020). Time course of lung changes on chest CT during recovery from
2019 novel coronavirus (COVID-19) pneumonia. Radiology, 200370.
- Papp, M., Li, X., Zhuang, J., Wang, R., & Uhal, B. D. (2002).
Angiotensin receptor subtype AT1 mediates alveolar epithelial cell
apoptosis in response to ANG II. American Journal of Physiology-Lung
Cellular and Molecular Physiology, 282(4), L713-L718.
- Parra, E. R., Ruppert, A. D. P., & Capelozzi, V. L. (2014).
Angiotensin II type 1 and 2 receptors and lymphatic vessels modulate
lung remodeling and fibrosis in systemic sclerosis and idiopathic
pulmonary fibrosis. Clinics, 69(1), 47-54.
- Patel, A. B., & Verma, A. (2020). COVID-19 and Angiotensin-Converting
Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the
Evidence? JAMA. doi:10.1001/jama.2020.4812
- Patel, V. B., Clarke, N., Wang, Z., Fan, D., Parajuli, N., Basu, R.,
… & Oudit, G. Y. (2014). Angiotensin II induced proteolytic
cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive
feedback mechanism in the RAS. Journal of molecular and cellular
cardiology, 66, 167-176.
- Patel, V. B., Zhong, J. C., Grant, M. B., & Oudit, G. Y. (2016). Role
of the ACE2/angiotensin 1–7 axis of the renin–angiotensin system in
heart failure. Circulation research, 118(8), 1313-1326.
- Pedersen, S. F., & Ho, Y. C. (2020). SARS-CoV-2: A Storm is Raging.
The Journal of Clinical Investigation.
- Phadke, M., & Saunik, S. (2020). Rapid response: Use of angiotensin
receptor blockers such as Telmisartan, Losartsan in nCoV Wuhan Corona
Virus infections—Novel mode of treatment. Response to the emerging
novel coronavirus outbreak. BMJ, 368, m406.
- Pickel, L., Matsuzuka, T., Doi, C., Ayuzawa, R., Maurya, D. K., Xie,
S. X., … & Tamura, M. (2010). Over-expression of angiotensin II
type 2 receptor gene induces cell death in lung adenocarcinoma cells.
Cancer biology & therapy, 9(4), 277-285.
- Pires-Neto, R. C., Morales, M.
M. B., Lancas, T., Inforsato, N., Duarte, M. I. S., Amato, M. B. P.,
… & Dolhnikoff, M. (2013). Expression of acute-phase cytokines,
surfactant proteins, and epithelial apoptosis in small airways of
human acute respiratory distress syndrome. Journal of critical care,
28(1), 111-e9.
- Povlsen, A. L., Grimm, D., Wehland, M., Infanger, M., & Krüger, M.
(2020). The Vasoactive Mas Receptor in Essential Hypertension. Journal
of Clinical Medicine, 9(1), 267.
- Prompetchara, E., Ketloy, C., & Palaga, T. (2020). Immune responses
in COVID-19 and potential vaccines: Lessons learned from SARS and MERS
epidemic. Asian Pac J Allergy Immunol, 38, 1-9.
- Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., … & Tian,
D. S. (2020). Dysregulation of immune response in patients with
COVID-19 in Wuhan, China. China (February 17, 2020).
- Reyes, S., Varagic, J., Ahmad, S., VonCannon, J., Kon, N. D., Wang,
H., … & Ferrario, C. M. (2017). Novel cardiac intracrine mechanisms
based on Ang-(1-12)/chymase axis require a revision of therapeutic
approaches in human heart disease. Current hypertension reports,
19(2), 16.
- Rodrigues-Díez, R.,
Carvajal-González, G., Sánchez-López, E., Rodríguez-Vita, J., Díez, R.
R., Selgas, R., … & Ruiz-Ortega, M. (2008). Pharmacological
modulation of epithelial mesenchymal transition caused by angiotensin
II. Role of ROCK and MAPK pathways. Pharmaceutical research, 25(10),
2447-2461.
- Rothan, H. A., & Byrareddy, S.
N. (2020). The epidemiology and pathogenesis of coronavirus disease
(COVID-19) outbreak. Journal of Autoimmunity, 102433.
- Rzepka, J. P., Haick, A. K., &
Miura, T. A. (2012). Virus-infected alveolar epithelial cells direct
neutrophil chemotaxis and inhibit their apoptosis. American journal of
respiratory cell and molecular biology, 46(6), 833-841.
- Sakai, N., & Tager, A. M. (2013). Fibrosis of two: Epithelial
cell-fibroblast interactions in pulmonary fibrosis. Biochimica et
Biophysica Acta (BBA)-Molecular Basis of Disease, 1832(7), 911-921.
- Santos, R. A. (2014). Angiotensin-(1–7). Hypertension, 63(6),
1138-1147.
- Santos, R. A. S., Oudit, G. Y., Verano-Braga, T., Canta, G.,
Steckelings, U. M., & Bader, M. (2019). The renin-angiotensin system:
going beyond the classical paradigms. American Journal of
Physiology-Heart and Circulatory Physiology, 316(5), H958-H970.
- Santos, R. A. S., Sampaio, W. O., Alzamora, A. C., Motta-Santos, D.,
Alenina, N., Bader, M., & Campagnole-Santos, M. J. (2018). The
ACE2/angiotensin-(1–7)/MAS axis of the renin-angiotensin system:
focus on angiotensin-(1–7). Physiological reviews, 98(1), 505-553.
- Schmermund, A., Lerman, L. O., Ritman, E. L., & Rumberger, J. A.
(1999, May). Cardiac production of angiotensin II and its
pharmacologic inhibition: effects on the coronary circulation. In Mayo
Clinic Proceedings (Vol. 74, No. 5, pp. 503-513). Elsevier.
- Shao, M., Wen, Z. B., Yang, H. H., Zhang, C. Y., Xiong, J. B., Guan,
X. X., … & He, X. F. (2019). Exogenous angiotensin (1-7) directly
inhibits epithelial-mesenchymal transformation induced by transforming
growth factor-β1 in alveolar epithelial cells. Biomedicine &
Pharmacotherapy, 117, 109193.
- Shen, L., Mo, H., Cai, L., Kong, T., Zheng, W., Ye, J., … & Xiao,
Z. (2009). losartan prevents sepsis-induced acute lung injury and
decreases activation of nuclear factorκb and mitogen-activated protein
kinases. Shock, 31(5), 500-506.
- Shi, J., Wen, Z., Zhong, G., Yang, H., Wang, C., Huang, B., … &
Zhao, Y. (2020). Susceptibility of ferrets, cats, dogs, and other
domesticated animals to SARS–coronavirus 2. Science.
- Shrikrishna, D., Astin, R., Kemp, P. R., & Hopkinson, N. S. (2012).
Renin–angiotensin system blockade: a novel therapeutic approach in
chronic obstructive pulmonary disease. Clinical science, 123(8),
487-498.
- Singh, V. P., Baker, K. M., & Kumar, R. (2008). Activation of the
intracellular renin-angiotensin system in cardiac fibroblasts by high
glucose: role in extracellular matrix production. American Journal of
Physiology-Heart and Circulatory Physiology, 294(4), H1675-H1684.
- Skov, J., Persson, F., Frøkiær, J., & Christiansen, J. S. (2014).
Tissue renin–angiotensin systems: a unifying hypothesis of metabolic
disease. Frontiers in endocrinology, 5, 23.
- Sodhi, C. P., Nguyen, J., Yamaguchi, Y., Werts, A. D., Lu, P., Ladd,
M. R., … & Zhang, Y. (2019). A Dynamic Variation of Pulmonary ACE2
Is Required to Modulate Neutrophilic Inflammation in Response to
Pseudomonas aeruginosa Lung Infection in Mice. The Journal of
Immunology, 203(11), 3000-3012.
- Sriram, K., & Insel, P. A. (2020). Dangers of ACE inhibitor and ARB
usage in COVID-19: evaluating the evidence. medRxiv.
- Stebbing, J., Phelan, A., Griffin, I., Tucker, C., Oechsle, O., Smith,
D., & Richardson, P. (2020). COVID-19: combining antiviral and
anti-inflammatory treatments. The Lancet Infectious Diseases.
- Suk, J. S., & Ensign-Hodges, L. (2019). Development of Angiotensin II
Receptor Blocker Nanoparticles for an Inhaled Therapeutic Treatment of
COPD via TGF-Beta Antagonism (Doctoral dissertation, Johns Hopkins
University).
- Sun, P., Lu, X., Xu, C., Sun, W., & Pan, B. (2020). Understanding of
COVID‐19 based on current evidence. Journal of medical virology.
- Sutton, T. C., & Subbarao, K. (2015). Development of animal models
against emerging coronaviruses: From SARS to MERS coronavirus.
Virology, 479, 247-258.
- Thevarajan, I., Nguyen, T. H., Koutsakos, M., Druce, J., Caly, L., van
de Sandt, C. E., … & Tong, S. Y. (2020). Breadth of concomitant
immune responses prior to patient recovery: a case report of
non-severe COVID-19. Nature Medicine, 1-3.
- Tian, S., Hu, W., Niu, L., Liu, H., Xu, H., & Xiao, S. Y. (2020).
Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19)
pneumonia in two patients with lung cancer. Journal of Thoracic
Oncology.
- Tikellis, C., & Thomas, M. C. (2012). Angiotensin-converting enzyme 2
(ACE2) is a key modulator of the renin angiotensin system in health
and disease. International journal of peptides, 2012.
- To, K. K. W., Tsang, O. T. Y., Leung, W. S., Tam, A. R., Wu, T. C.,
Lung, D. C., … & Lau, D. P. L. (2020). Temporal profiles of viral
load in posterior oropharyngeal saliva samples and serum antibody
responses during infection by SARS-CoV-2: an observational cohort
study. The Lancet Infectious Diseases.
- Uhal, B. D., Dang, M. T. T., Li, X., & Abdul-Hafez, A. (2012).
Angiotensinogen gene transcription in pulmonary fibrosis.
International journal of peptides, 2012.
- Uhal, B. D., Kyong Kim, J., Li, X., & Molina-Molina, M. (2007).
Angiotensin-TGF-β1 crosstalk in human idiopathic pulmonary fibrosis:
autocrine mechanisms in myofibroblasts and macrophages. Current
pharmaceutical design, 13(12), 1247-1256.
- Uhal, B. D., Li, X., Piasecki, C. C., & Molina-Molina, M. (2012b).
Angiotensin signalling in pulmonary fibrosis. The international
journal of biochemistry & cell biology, 44(3), 465-468.
- Uhal, B. D., Li, X., Xue, A., Gao, X., & Abdul-Hafez, A. (2011).
Regulation of alveolar epithelial cell survival by the
ACE-2/angiotensin 1–7/Mas axis. American Journal of Physiology-Lung
Cellular and Molecular Physiology, 301(3), L269-L274.
- Uhal, B. D., Nguyen, H., Dang, M., Gopallawa, I., Jiang, J., Dang, V.,
… & Morimoto, K. (2013). Abrogation of ER stress-induced apoptosis
of alveolar epithelial cells by angiotensin 1–7. American Journal of
Physiology-Lung Cellular and Molecular Physiology, 305(1), L33-L41.
- Vaduganathan, M., Vardeny, O., Michel, T., McMurray, J. J., Pfeffer,
M. A., & Solomon, S. D. (2020). Renin–Angiotensin–Aldosterone
System Inhibitors in Patients with Covid-19. New England Journal of
Medicine. doi: 10.1056/NEJMsr2005760
- van de Garde, E. M., Souverein, P. C., Hak, E., Deneer, V. H., van den
Bosch, J. M., & Leufkens, H. G. (2007). Angiotensin-converting enzyme
inhibitor use and protection against pneumonia in patients with
diabetes. Journal of hypertension, 25(1), 235-239.
- Walls, A. C., Park, Y. J., Tortorici, M. A., Wall, A., McGuire, A. T.,
& Veesler, D. (2020). Structure, function, and antigenicity of the
SARS-CoV-2 spike glycoprotein. Cell.
- Wan, Y., Shang, J., Graham, R., Baric, R. S., & Li, F. (2020).
Receptor recognition by the novel coronavirus from Wuhan: an analysis
based on decade-long structural studies of SARS coronavirus. Journal
of virology, 94(7).
- Wang, D., Chai, X. Q., Magnnusen, C. G., Zosky, G. R., Shu, S. H.,
Wei, X., & Hu, S. S. (2019). Renin-angiotensin-system, a potential
pharmacological candidate, in acute respiratory distress syndrome
during mechanical ventilation. Pulmonary pharmacology & therapeutics,
101833.
- Wang, L., Wang, Y., Yang, T., Guo, Y., & Sun, T. (2015).
Angiotensin-converting enzyme 2 attenuates bleomycin-induced lung
fibrosis in mice. Cellular Physiology and Biochemistry, 36(2),
697-711.
- Wang, R., Alam, G., Zagariya, A., Gidea, C., Pinillos, H., Lalude, O.,
… & Uhal, B. D. (2000). Apoptosis of lung epithelial cells in
response to TNF‐α requires angiotensin II generation de novo. Journal
of cellular physiology, 185(2), 253-259.
- Wang, R., Ramos, C., Joshi, I., Zagariya, A., Pardo, A., Selman, M.,
& Uhal, B. D. (1999a). Human lung myofibroblast-derived inducers of
alveolar epithelial apoptosis identified as angiotensin peptides.
American Journal of Physiology-Lung Cellular and Molecular Physiology,
277(6), L1158-L1164.
- Wang, R., Zagariya, A., Ang, E., Ibarra-Sunga, O., & Uhal, B. D.
(1999b). Fas-induced apoptosis of alveolar epithelial cells requires
ANG II generation and receptor interaction. American Journal of
Physiology-Lung Cellular and Molecular Physiology, 277(6),
L1245-L1250.
- Wang, R., Zagariya, A., Ibarra-Sunga, O., Gidea, C., Ang, E.,
Deshmukh, S., … & Uhal, B. D. (1999c). Angiotensin II induces
apoptosis in human and rat alveolar epithelial cells. American Journal
of Physiology-Lung Cellular and Molecular Physiology, 276(5),
L885-L889.
- Waseda, Y., Yasui, M., Nishizawa, Y., Inuzuka, K., Takato, H.,
Ichikawa, Y., … & Nakao, S. (2008). Angiotensin II type 2 receptor
antagonist reduces bleomycin-induced pulmonary fibrosis in mice.
Respiratory research, 9(1), 43.
- Watanabe, T., Barker, T. A., & Berk, B. C. (2005). Angiotensin II and
the endothelium: diverse signals and effects. Hypertension, 45(2),
163-169.
- Wen, H., Gwathmey, J. K., & Xie, L. H. (2012). Oxidative
stress-mediated effects of angiotensin II in the cardiovascular
system. World journal of hypertension, 2(4), 34.
- Wong, S. K., Li, W., Moore, M. J., Choe, H., & Farzan, M. (2004). A
193-amino acid fragment of the SARS coronavirus S protein efficiently
binds angiotensin-converting enzyme 2. Journal of Biological
Chemistry, 279(5), 3197-3201.
- Wösten-van Asperen, R. M., Lutter, R., Haitsma, J. J., Merkus, M. P.,
van Woensel, J. B., Van Der Loos, C. M., … & Bos, A. P. (2008). ACE
mediates ventilator-induced lung injury in rats via angiotensin II but
not bradykinin. European Respiratory Journal, 31(2), 363-371.
- Wösten‐van Asperen, R. M., Lutter, R., Specht, P. A., Moll, G. N., van
Woensel, J. B., van der Loos, C. M., … & Bos, A. P. (2011). Acute
respiratory distress syndrome leads to reduced ratio of ACE/ACE2
activities and is prevented by angiotensin‐(1–7) or an angiotensin II
receptor antagonist. The Journal of pathology, 225(4), 618-627.
- Wright, J. R. (2003). Pulmonary surfactant: a front line of lung host
defense. The Journal of clinical investigation, 111(10), 1453-1455.
- Wu, H., Li, Y., Wang, Y., Xu, D., Li, C., Liu, M., … & Li, Z.
(2014). Tanshinone IIA attenuates bleomycin-induced pulmonary fibrosis
via modulating angiotensin-converting enzyme 2/angiotensin-(1-7) axis
in rats. International journal of medical sciences, 11(6), 578.
- Wu, Z., & McGoogan, J. M.
(2020). Characteristics of and important lessons from the coronavirus
disease 2019 (COVID-19) outbreak in China: summary of a report of 72
314 cases from the Chinese Center for Disease Control and Prevention.
Jama.
- Xu, H., Zhong, L., Deng, J., Peng, J., Dan, H., Zeng, X., … & Chen,
Q. (2020a). High expression of ACE2 receptor of 2019-nCoV on the
epithelial cells of oral mucosa. International Journal of Oral
Science, 12(1), 1-5.
- Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., … &
Tai, Y. (2020b). Pathological findings of COVID-19 associated with
acute respiratory distress syndrome. The Lancet respiratory medicine.
- Yan, Y., Liu, Q., Li, N., Du, J., Li, X., Li, C., … & Jiang, C.
(2015). Angiotensin II receptor blocker as a novel therapy in acute
lung injury induced by avian influenza A H5N1 virus infection in
mouse. Science China Life Sciences, 58(2), 208-211.
- Yao, H. W., Zhu, J. P., Zhao, M. H., & Lu, Y. (2006). Losartan
attenuates bleomycin-induced pulmonary fibrosis in rats. Respiration,
73(2), 236-242.
- Yasui, F., Kohara, M., Kitabatake, M., Nishiwaki, T., Fujii, H.,
Tateno, C., … & Kai, C. (2014). Phagocytic cells contribute to the
antibody-mediated elimination of pulmonary-infected SARS coronavirus.
Virology, 454, 157-168.
- Zhang, H., Penninger, J. M., Li, Y., Zhong, N., & Slutsky, A. S.
(2020). Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2
receptor: molecular mechanisms and potential therapeutic target.
Intensive Care Medicine, 1-5.
- Zhang, Y., Li, Y., Shi, C., Fu, X., Zhao, L., & Song, Y. (2018).
Angiotensin‐(1‐7)‐mediated Mas1 receptor/NF‐κB‐p65 signaling is
involved in a cigarette smoke‐induced chronic obstructive pulmonary
disease mouse model. Environmental toxicology, 33(1), 5-15.
- Zhao, J., Zhao, J., Van Rooijen, N., & Perlman, S. (2009). Evasion by
stealth: inefficient immune activation underlies poor T cell response
and severe disease in SARS-CoV-infected mice. PLoS pathogens, 5(10).
- Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., … & Guan, L.
(2020a). Clinical course and risk factors for mortality of adult
inpatients with COVID-19 in Wuhan, China: a retrospective cohort
study. The Lancet. 395( 10229), P1054-1062
- Zhou, J. B., Yang, J. K., Lu, J. K., & An, Y. H. (2010).
Angiotensin-converting enzyme gene polymorphism is associated with
type 2 diabetes: a meta-analysis. Molecular biology reports, 37(1),
67-73.
- Zhou, P., Yang, X. L., Wang, X. G., Hu, B., Zhang, L., Zhang, W., …
& Chen, H. D. (2020b). A pneumonia outbreak associated with a new
coronavirus of probable bat origin. Nature, 579(7798), 270-273.
- Zou, X., Chen, K., Zou, J., Han, P., Hao, J., & Han, Z. (2020).
Single-cell RNA-seq data analysis on the receptor ACE2 expression
reveals the potential risk of different human organs vulnerable to
2019-nCoV infection. Frontiers of Medicine, 1-8.